BioLife Solutions, Inc.
BLFS
$35.07
-$0.16-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 108.80M | 103.77M | 98.32M | 88.67M | 81.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 108.80M | 103.77M | 98.32M | 88.67M | 81.99M |
| Cost of Revenue | 39.58M | 37.60M | 34.85M | 30.05M | 27.31M |
| Gross Profit | 69.22M | 66.17M | 63.47M | 58.61M | 54.68M |
| SG&A Expenses | 56.28M | 56.61M | 55.67M | 55.36M | 52.59M |
| Depreciation & Amortization | 1.01M | 916.00K | 897.00K | -960.00K | -976.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 107.24M | 104.52M | 99.60M | 89.32M | 82.97M |
| Operating Income | 1.55M | -747.00K | -1.27M | -651.00K | -980.00K |
| Income Before Tax | 6.64M | -11.31M | -12.27M | -13.74M | -14.99M |
| Income Tax Expenses | -42.38M | 97.00K | 49.00K | 246.00K | 84.00K |
| Earnings from Continuing Operations | 49.02 | -11.41 | -12.32 | -13.98 | -15.08 |
| Earnings from Discontinued Operations | 8.96M | 8.44M | 7.73M | 10.78M | 9.55M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.98M | -2.96M | -4.60M | -3.21M | -5.53M |
| EBIT | 1.55M | -747.00K | -1.27M | -651.00K | -980.00K |
| EBITDA | 4.98M | 2.41M | 1.69M | 3.43M | 4.08M |
| EPS Basic | 1.19 | -0.06 | -0.10 | -0.06 | -0.11 |
| Normalized Basic EPS | 0.08 | 0.05 | 0.04 | 0.02 | 0.01 |
| EPS Diluted | 1.16 | -0.08 | -0.11 | -0.07 | -0.12 |
| Normalized Diluted EPS | 0.08 | 0.05 | 0.04 | 0.02 | 0.01 |
| Average Basic Shares Outstanding | 193.39M | 192.33M | 191.00M | 189.51M | 187.76M |
| Average Diluted Shares Outstanding | 196.28M | 194.78M | 193.90M | 192.92M | 190.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |